Antisense Inhibitors of ApoC3 and Lp(a) Show Positive Results in Phase 1 and 2 Studies
In a Phase 2 trial, patients with very high to
August 5, 2015
In a Phase 2 trial, patients with very high to
Which of the many so called โrisk factorsโ correlated with
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
